Today on Outsourcing-Pharma.com   GSK's disdain is blatant over new rules for patent Indian firm takes over German biologics plant Clinical contract news in brief Best biopharma bosses Moss protein factories scaled up

Related Industry News   Billionaire 'raider' circles as Biogen put up for sale Billionaire 'raider' circles as Biogen put up for sale GSK, Synta join forces in billion dollar cancer deal FDA backs tablet imaging tech

Breaking News on Outsourcing Pharma
Daily  Monday 15 October 2007		Forward to a colleague

	Company Profile DPT - The Industry Source for Semi-solids and Liquids. DPT is a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms providing solutions from concept to commercialization. Click here to learn more about our services... Click Here Access Full Stories GSK's disdain is blatant over new rules for patent GlaxoSmithkline (GSK) has expressed its disdain for looming changes to drug patent application rules in the US and has launched a lawsuit to try and stop them coming into force next month... Read Indian firm takes over German biologics plant An Indian firm has taken over the contract biologics manufacturing business of German corporation Siegfried... Read Clinical contract news in brief Outsourcing-Pharma.com compiles the news that has featured in the clinical contract community of late involving Clinsys, Averion, PRA International and others... Read Best biopharma bosses There have been a few changes in the top ten employers according to leading journal Science's annual survey of the best companies to work for in the biotech, biopharma, pharmaceutical and related industries... Read Moss protein factories scaled up Normally, they are green, sort of spongy and found in dank nooks and crannies - but mosses have now been designed as therapeutic protein producing factories and are being implemented on a grand scale... Read
	All News Headlines for: October | September | August
	Related Industry News Billionaire 'raider' circles as Biogen put up for sale Biogen Idec has announced it is seeking a buyer for the company and has already received several expressions of interest - including a reputed $23bn (€16.2bn) bid from billionaire corporate raider Carl Icahn... Read Billionaire 'raider' circles as Biogen put up for sale Biogen Idec has announced it is seeking a buyer for the company and has already received several expressions of interest - including a reputed $23bn (€16.2bn) bid from billionaire corporate raider Carl Icahn... Read GSK, Synta join forces in billion dollar cancer deal GlaxoSmithKline (GSK) has signed a deal worth around a billion dollars with US biopharma firm Synta, over its first-in-class melanoma drug, a notoriously difficult cancer to treat... Read FDA backs tablet imaging tech UK-based TeraView has had its tablet imaging technology backed by the US Food and Drug Administration (FDA), following a study by the regulatory agency... Read Weekly Comment FDA told its safety monitoring of clinical trials not good enough The US Food and Drug Administration (FDA) has been called into question again after the release of a damning report, this time suggesting the agency is inadequate in its safety monitoring of clinical trials. Read Previous Headlines Clinical trials in emerging regions: where is best? There is much confusion over the competing lure of the four major emerging regions for clinical trials, although each have their pros and cons... Read India's Indoco pursuing the West Indian contract formulations specialist Indoco has been actively angling itself to compete more heartily in the western market... Read Avecia takes on new MS drug Avecia Biologics has signed a development and manufacturing deal with US firm BaroFold, making use of the company's protein processing technology to produce its lead interferon-based multiple sclerosis (MS) candidate... Read Kinaxo adds new proteomics service Kinaxo Biotechnologies is now offering a new proteomics service to help drug developers decide which drug candidates to move through the preclinical process... Read Cosmo lands partner for world-first drug Italian firm Cosmo Pharmaceuticals today announced a licensing agreement with Ferring for its reformulated budesonide product, predicted to be the first oral corticosteroid for ulcerative colitis approved worldwide... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analytical testing, QC Bulk ingredients Contract sales & marketing Data management Drug delivery, formulation Fill & finish, packaging Phase I-II Phase III-IV Preclinical Product & Supplier News - Contract Manufacturing Regulatory affairs Supply chain, logistics Validation services

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@OutSourcing-Pharma.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com